SE414633B - Forfarande for framstellning av nya 4-(3-tert butylamino-propoxi)-2-metyl-indolderivat med terapeutisk verkan - Google Patents
Forfarande for framstellning av nya 4-(3-tert butylamino-propoxi)-2-metyl-indolderivat med terapeutisk verkanInfo
- Publication number
- SE414633B SE414633B SE7608865A SE7608865A SE414633B SE 414633 B SE414633 B SE 414633B SE 7608865 A SE7608865 A SE 7608865A SE 7608865 A SE7608865 A SE 7608865A SE 414633 B SE414633 B SE 414633B
- Authority
- SE
- Sweden
- Prior art keywords
- indold
- propoxy
- derivatives
- methyl
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1071475 | 1975-08-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7608865L SE7608865L (sv) | 1977-02-16 |
SE414633B true SE414633B (sv) | 1980-08-11 |
Family
ID=4366041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7608865A SE414633B (sv) | 1975-08-15 | 1976-08-06 | Forfarande for framstellning av nya 4-(3-tert butylamino-propoxi)-2-metyl-indolderivat med terapeutisk verkan |
Country Status (28)
Country | Link |
---|---|
US (1) | US4434176A (sv) |
JP (2) | JPS5223073A (sv) |
AT (1) | AT363070B (sv) |
AU (1) | AU505719B2 (sv) |
BE (1) | BE845197R (sv) |
CA (1) | CA1080720A (sv) |
CY (1) | CY1225A (sv) |
DE (1) | DE2635209C2 (sv) |
DK (1) | DK152120C (sv) |
ES (1) | ES450681A1 (sv) |
FI (1) | FI63751C (sv) |
FR (1) | FR2320743A2 (sv) |
GB (2) | GB1575509A (sv) |
HK (1) | HK35884A (sv) |
IE (1) | IE43797B1 (sv) |
IL (2) | IL50263A (sv) |
KE (1) | KE3404A (sv) |
MY (1) | MY8500135A (sv) |
NL (2) | NL176362C (sv) |
NO (1) | NO762735L (sv) |
NZ (1) | NZ181764A (sv) |
PH (1) | PH13356A (sv) |
PT (1) | PT65477B (sv) |
SE (1) | SE414633B (sv) |
SG (1) | SG84883G (sv) |
SU (1) | SU649313A3 (sv) |
YU (1) | YU198876A (sv) |
ZA (1) | ZA764883B (sv) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2830211A1 (de) * | 1977-07-21 | 1979-02-01 | Sandoz Ag | Substituierte indol-derivate, ihre herstellung und verwendung |
JPS58106499A (ja) * | 1981-12-19 | 1983-06-24 | 株式会社東芝 | 燃料交換装置のクランプ解除機構 |
NL8600137A (nl) * | 1985-02-05 | 1986-09-01 | Sandoz Ag | Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten. |
US5174210A (en) * | 1990-04-27 | 1992-12-29 | Heidelberger Druckmaschinen Aktiengesellschaft | Preparation of the inking unit of a printing press for a change of printing job |
WO1995020568A1 (en) * | 1994-01-28 | 1995-08-03 | Cal International Limited | Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
JP4901474B2 (ja) * | 2003-05-30 | 2012-03-21 | ランバクシー ラボラトリーズ リミテッド | 置換ピロール誘導体 |
KR101329112B1 (ko) * | 2005-11-08 | 2013-11-14 | 랜박시 래보러터리스 리미티드 | (3r,5r)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법 |
US20070238716A1 (en) * | 2006-03-14 | 2007-10-11 | Murthy Ayanampudi S R | Statin stabilizing dosage formulations |
EP2049102A4 (en) * | 2006-07-14 | 2010-12-22 | Ranbaxy Lab Ltd | POLYMORPHIC FORMS OF AN HMG COA REDUCTASE HEATHER AND USE |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH532040A (de) * | 1970-03-24 | 1972-12-31 | Sandoz Ag | Verfahren zur Herstellung neuer Indolderivate |
US3751429A (en) * | 1970-03-24 | 1973-08-07 | Sandoz Ltd | 4-(3-amino-2-substituted propoxy)indole derivatives |
SE375771B (sv) * | 1970-09-30 | 1975-04-28 | Sandoz Ag | |
CH545784A (en) * | 1971-01-07 | 1974-02-15 | Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles | |
CH545783A (en) * | 1971-01-07 | 1974-02-15 | Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides |
-
1976
- 1976-08-05 DE DE2635209A patent/DE2635209C2/de not_active Expired
- 1976-08-06 NO NO762735A patent/NO762735L/no unknown
- 1976-08-06 DK DK357576A patent/DK152120C/da not_active IP Right Cessation
- 1976-08-06 FI FI762258A patent/FI63751C/fi not_active IP Right Cessation
- 1976-08-06 SE SE7608865A patent/SE414633B/sv unknown
- 1976-08-11 NL NLAANVRAGE7608902,A patent/NL176362C/xx active Protection Beyond IP Right Term
- 1976-08-12 YU YU01988/76A patent/YU198876A/xx unknown
- 1976-08-12 FR FR7624659A patent/FR2320743A2/fr active Granted
- 1976-08-13 IE IE1791/76A patent/IE43797B1/en not_active IP Right Cessation
- 1976-08-13 AT AT0602576A patent/AT363070B/de not_active IP Right Cessation
- 1976-08-13 CY CY1125A patent/CY1225A/xx unknown
- 1976-08-13 ZA ZA00764883A patent/ZA764883B/xx unknown
- 1976-08-13 ES ES450681A patent/ES450681A1/es not_active Expired
- 1976-08-13 IL IL50263A patent/IL50263A/xx unknown
- 1976-08-13 NZ NZ181764A patent/NZ181764A/xx unknown
- 1976-08-13 BE BE169821A patent/BE845197R/xx active
- 1976-08-13 GB GB33753/76A patent/GB1575509A/en not_active Expired
- 1976-08-13 PH PH18788A patent/PH13356A/en unknown
- 1976-08-13 GB GB13931/79A patent/GB1575510A/en not_active Expired
- 1976-08-13 PT PT65477A patent/PT65477B/pt unknown
- 1976-08-13 SU SU762388420A patent/SU649313A3/ru active
- 1976-08-13 CA CA259,050A patent/CA1080720A/en not_active Expired
- 1976-08-13 AU AU16841/76A patent/AU505719B2/en not_active Expired
- 1976-08-14 JP JP51096629A patent/JPS5223073A/ja active Granted
-
1979
- 1979-09-03 IL IL58163A patent/IL58163A0/xx unknown
-
1980
- 1980-05-23 JP JP6800480A patent/JPS5649318A/ja active Pending
-
1982
- 1982-05-06 US US06/375,369 patent/US4434176A/en not_active Expired - Lifetime
-
1983
- 1983-12-29 SG SG848/83A patent/SG84883G/en unknown
-
1984
- 1984-04-19 KE KE3404A patent/KE3404A/xx unknown
- 1984-04-26 HK HK358/84A patent/HK35884A/xx unknown
-
1985
- 1985-12-30 MY MY135/85A patent/MY8500135A/xx unknown
-
1993
- 1993-07-02 NL NL930134C patent/NL930134I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE434395B (sv) | Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan | |
SE423544B (sv) | Analogiforfarande for framstellning av imidazolderivat med antifungisk aktivitet | |
SE429338B (sv) | Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan | |
SE414633B (sv) | Forfarande for framstellning av nya 4-(3-tert butylamino-propoxi)-2-metyl-indolderivat med terapeutisk verkan | |
SE411671B (sv) | Forfarande for framstellning av tripeptidderivat med terapeutisk verkan | |
SE7514308L (sv) | Forfarande for framstellning av tyrosinderivat med terapeutisk verkan | |
SE7600343L (sv) | Forfarande for framstellning av ferrocenderivat med terapeutisk verkan | |
SE7608538L (sv) | Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan | |
SE7703721L (sv) | Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan | |
SE392722B (sv) | Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan | |
SE7608115L (sv) | Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan | |
SE421917B (sv) | Analogiforfarande for framstellning av nya derivat av 2-metyl-1-indolyl-ettikssyra med terapeutisk verkan | |
SE398230B (sv) | Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan | |
SE7606815L (sv) | Forfarande for framstellning av nya naftacenderivat | |
SE394429B (sv) | Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan | |
SE7805105L (sv) | Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan | |
SE7713839L (sv) | Forfarande for framstellning av indanderivat med terapeutisk verkan | |
SE393980B (sv) | Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan | |
SE7712219L (sv) | Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan | |
SE411119B (sv) | Analogiforfarande for framstellning av l-indolin-l-yl-guanidinderivat med terapeutisk verkan | |
SE409113B (sv) | Foerfarande foer framstaellning av nya derivat av n-amino-3-fenylindoler med terapeutiska egenskaper | |
SE7606236L (sv) | Forfarande for framstellning av piperazinforeningar med terapeutisk verkan | |
SE385897B (sv) | Forfarande for framstellning av bensoditianpyronderivat med terapeutisk verkan | |
SE417712B (sv) | Forfarande for framstellning av n-(6-acyloxibensotiazol-2-yl)-n-fenylkarbamider med terapeutisk verkan | |
SE7701551L (sv) | Forfarande for framstellning av bensenkarboxamidderivat med terapeutisk verkan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7608865-7 Format of ref document f/p: F |